Occlusion types, therapy, recanalization and lesion volumes L0-LG7
| Occlusion | n | rt-PA | Recanalization Day 7 | L0 | LG1 | LG7 | ST7 |
|---|---|---|---|---|---|---|---|
| ICA/MCA | 1 | 1 | 0 | 18.2 | 28.7 | 33.5 | 197.5 |
| Carotid T | 5 | 5 | 3 | 16.3 | 36.8 | 34.8 | 150.9 |
| 0.6–80.3 | 11.7–128.4 | 10.1–71.6 | 68.3–177.0 | ||||
| M1/2 | 7 | 4 | 5 | 18.0 | 17.9 | 4.4 | 166.3 |
| 7.0–78.8 | 1.7–44.1 | 0.2–16.2 | 94.8–180.6 | ||||
| MCA-branch | 6 | 3 | 5 | 30.1 | 9.7 | 1.0 | 41.7 |
| 0.1–70.9 | 0.3–30.2 | 0.6–2.6 | 11.1–97.0 |
Note.—ICA/MCA indicates occlusion of the internal carotid artery with accompanying occlusion of the middle cerebral artery; CTO, occlusion of the intracranial ICA bifurcation (carotid T occlusion), MCA occlusion of the trunk or trifurcation (M1/2), and MCA branch occlusion (segments M3 and M4); rt-PA, recombinant tissue plasminogen activator; L0, lesion at day 0 defined by a reduced apparent diffusion coefficient (ADC); LG1 and LG7, lesion growth on T2-weighted images until day 1 and 7; and ST7 = surviving tissue at day 7 (tissue with initially reduced cerebral blood flow but without T2 prolongation at day 7). Volumes are median and range (min–max).